Recombinant factor IX Fc prophylaxis reduces pain and increases levels of physical activity, with sustained, long-term improvements in patients with hemophilia B: analysis of phase III trials using patient-reported outcomes.

Journal: Therapeutic advances in hematology

Publication date: 

Journal: Therapeutic advances in hematology

Publication Year: 

Authors & Co-authors:  Astermark Jan J Hermans Cédric C Ezzalfani Monia M Sidhom Alaeddine A Barbier Sylvaine S Kragh Nana N Falk Aletta A Eriksson Daniel D